Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
15:12:35 EDT Fri 19 Apr 2024
Enter Symbol
or Name
USA
CA



Q:ENTA - ENANTA PHARMACEUTICALS INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ENTA - Q0.112.99·13.012.813.00-0.23-1.784.21,04089813.105  13.44  12.7737.75  8.0814:51:57Apr 1715 min RT 2¢

Recent Trades - Last 10 of 898
Time ETExPriceChangeVolume
14:51:57Q13.00-0.2333
14:51:52Q13.00-0.23100
14:51:52Q13.00-0.23100
14:51:52Q13.00-0.23100
14:51:52Q13.00-0.23103
14:51:52Q13.00-0.23100
14:51:51Q13.025-0.20510
14:51:51Q13.025-0.20510
14:51:51Q13.025-0.20510
14:51:51Q13.025-0.20510

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-17 07:00U:ENTANews ReleaseEnanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
2024-03-06 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
2024-02-07 16:01U:ENTANews ReleaseEnanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET
2024-02-06 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
2024-01-31 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023
2024-01-04 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2024 Outlook at the 42nd Annual J.P. Morgan Healthcare Conference
2024-01-03 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2023-11-22 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Participate at Evercore ISI HealthCONx Conference
2023-11-20 16:01U:ENTANews ReleaseEnanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2023, with Webcast and Conference Call Today at 4:30 p.m. ET
2023-11-13 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Host Conference Call on November 20 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Fourth Quarter and Full Year Ended September 30, 2023
2023-10-13 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Host Virtual Key Opinion Leader Event to Discuss Advances in the Treatment Landscape for Respiratory Syncytial Virus (RSV) and its Proprietary RSV Pipeline
2023-09-17 12:00U:ENTANews ReleaseEnanta Pharmaceuticals to Present Data for EDP-323, its Oral, Once-Daily, L-Protein Inhibitor in Development for the Treatment of Respiratory Syncytial Virus, at the 9th ESWI Influenza Conference
2023-09-07 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Present Data for EDP-938, its Oral, Once-Daily, N-Protein Inhibitor in Development for the Treatment of Respiratory Syncytial Virus, at IDWeek ¢ „ ¢ 2023
2023-08-31 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Participate in Investor Conferences in September
2023-08-07 16:01U:ENTANews ReleaseEnanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter with Conference Call and Webcast Today at 4:30 p.m. ET
2023-07-31 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Host Conference Call on August 7 at 4:30 p.m. ET to Discuss its Financial Results for Its Fiscal Third Quarter Ended June 30, 2023
2023-06-20 07:00U:ENTANews ReleaseEnanta Pharmaceuticals Announces Positive Data From a Phase 1 Clinical Study of EDP-323, an Oral, L-Protein Inhibitor in Development for the Treatment of Respiratory Syncytial Virus
2023-06-07 07:00U:ENTANews ReleaseEnanta Pharmaceuticals Announces Data Presentation at the European Association for the Study of the Liver (EASL) International Liver Congress ¢ „ ¢ 2023
2023-05-31 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Participate at Jefferies Global Healthcare Conference
2023-05-09 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Participate in Two Investor Conferences in May